Search results
Results From The WOW.Com Content Network
Vaccine equity means ensuring that everyone in the world has equal access to vaccines. [ 1 ] [ 2 ] The importance of vaccine equity has been emphasized by researchers and public health experts during the COVID-19 pandemic [ 3 ] but is relevant to other illnesses and vaccines as well.
This information is used to make evidence-based decisions regarding vaccines and immunization policies. [1] [2] The majority of industrialized countries, as well as some developing countries, have formally established advisory committees to guide their immunization policies, while other countries are working towards establishing such committees ...
GAVI, officially Gavi, the Vaccine Alliance [1] (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) [2] is a public–private global health partnership with the goal of increasing access to immunization in poor countries. [3]
Charlize Theron and Misty Copeland came together Thursday night at the reopening of Breitling’s New York flagship store to talk about the philanthropic work that have been hallmarks of their ...
People of color have experienced a disproportionate amount of suffering in the coronavirus pandemic, but are being vaccinated at a lower rate than white people.
Apr. 7—Getting shots into the arms of the state's most vulnerable elderly and minority residents remains a challenge, even as vaccine begins a steady flow into Pennsylvania, state officials said ...
Launch of the Coalition for Epidemic Preparedness Innovations, CEPI in 2017 at the World Economic Forum in Davos, Switzerland. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).
[53] [54] On 15 May, the government announced funding for a fast-track program called Operation Warp Speed to place multiple vaccine candidates into clinical trials by the fall of 2020 and manufacture 300 million doses of a licensed vaccine by January 2021. The project's chief advisor is Moncef Slaoui and its chief operating officer is General ...